| Trial ID: | L2437 |
| Source ID: | NCT01143948
|
| Associated Drug: |
Glargine & Glulisine
|
| Title: |
Various Insulin Regimens for Diabetic Inpatients With Cirrhosis Trial
|
| Acronym: |
VIRDICT
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes|Liver Cirrhosis
|
| Interventions: |
DRUG: Glargine & Glulisine|DRUG: Regular insulin|DRUG: NPH & regular insulin
|
| Outcome Measures: |
Primary: optimal glycemic control in inpatient cirrhotics, 3-7 days | Secondary: Incidence of hypoglycemic episodes, 3-7 days
|
| Sponsor/Collaborators: |
Sponsor: Cairo University | Collaborators: Sanofi
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
45
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2011-01
|
| Completion Date: |
2011-05
|
| Results First Posted: |
|
| Last Update Posted: |
2010-06-15
|
| Locations: |
Internal medicine hospital ,Cairo University, Cairo, 11956, Egypt
|
| URL: |
https://clinicaltrials.gov/show/NCT01143948
|
